Skip to Main Content

Paper Details

The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
Clin Cancer Res
68
2019
CD68, CD68+, CD68+ cells, CD8, CD8+, CD8+ cells, HER2, HR, HR+, HR+/, HR+/HER2- breast tumors, Hormone, Hormone Receptor, Hormone Receptor-Positive Breast Cancer, Hormone receptor, Hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer, PD-L1, RNA, breast tumors, gene, gene expression, immunosuppressive, immunosuppressive (M2-like) macrophage-specific genes, immunosuppressive macrophage, lymphocyte, macrophage, macrophages, myeloid, myeloid signatures, patients, sTIL, stromal tumor-infiltrating lymphocytes, tumor, tumor cells, tumors
Author NameAffiliation
Patrick J Danaher
Katherine A HoadleyUniversity of North Carolina School of Medicine
Katherine A HoadleyUniversity of North Carolina School of Medicine
Charles M PerouUniversity of North Carolina School of Medicine
Eric P WinerDana-Farber Cancer Institute
Ian E KropDana-Farber Cancer Institute
Sara M TolaneyDana-Farber Cancer Institute
  • 1 - 7

Datasets

Release 1.2